Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat (Q28325177)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

10

K Ulbrich

1 reference

17 September 2019

T K Yeung

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

J W Hopewell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

R H Simmonds

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

R Duncan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

O Bellini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

M Grandi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

F Spreafico

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

J Strohalm

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

language of work or name

English

0 references

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

17 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

105-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse

17 September 2019

cites work

1 reference

12 December 2020

Effects of doxorubicin on mouse heart catalase

1 reference

12 December 2020

Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft

1 reference

12 December 2020

Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro

1 reference

12 December 2020

Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers

1 reference

12 December 2020

A functional assessment of the relative cardiotoxicity of adriamycin and epirubicin in the rat.

1 reference

12 December 2020

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia

1 reference

12 December 2020

Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. A prospective randomized evaluation

1 reference

12 December 2020

A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.

1 reference

12 December 2020

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma

1 reference

12 December 2020

Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast

1 reference

12 December 2020

Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers

1 reference

12 December 2020

Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles

1 reference

12 December 2020

Effect of galactose on interaction of N-(2-hydroxypropyl)methacrylamide copolymers with hepatoma cells in culture: preliminary application to an anticancer agent, daunomycin

1 reference

12 December 2020

The relative toxicity of intravenous and intraperitoneal doses of epirubicin

1 reference

12 December 2020

Time- and dose-related modifications in cardiac function in rats after single intravenous doses of epirubicin

1 reference

12 December 2020

The pharmacokinetics of polymer-bound adriamycin

1 reference

12 December 2020

Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times

1 reference

12 December 2020

Increased therapeutic efficacy and reduced toxicity of doxorubicin linked to pyran copolymer via the side chain of the drug

1 reference

12 December 2020

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

1 reference

12 December 2020

Adriamycin experimental cardiomyopathy in Swiss mice. Different effects of two calcium antagonistic drugs on ADM - induced cardiomyopathy.

1 reference

12 December 2020

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

12 December 2020

Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects

1 reference

12 December 2020

Anthracycline analogs: the past, present, and future

1 reference

12 December 2020

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro

1 reference

12 December 2020

Doxorubicin concentrations in plasma and myocardium and their respective roles in cardiotoxicity

1 reference

12 December 2020

Comparison of the effectiveness of (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles

1 reference

12 December 2020

Lysosomal alterations in heart and liver of mice treated with doxorubicin

1 reference

12 December 2020

Rationale and strategy for prevention of anthracycline cardiotoxicity with the bisdioxopiperazine, ICRF-187.

1 reference

12 December 2020

Targeting of daunorubicin by association with DNA or proteins: a review.

1 reference

12 December 2020

Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00687318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1760851%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

17 September 2019

0 references

1 reference